Back
ESC Premium Access

Predictors of exercise capacity in patients with asymptomatic primary moderate to severe mitral regurgitation and preserved left ventricle ejection fraction

Session: Valvular heart disease and infective endocarditis e-posters
Topic: Mitral Valve Regurgitation
Speaker: Ms R. Dirsiene (Kaunas, LT)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Ms Ruta Dirsiene

Hospital of Lithuanian University of Health Sciences, Kaunas (Lithuania)
1 presentation
0 follower

130 more presentations in this session

Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis

Speaker: Doctor N. Ngiam (Singapore, SG)

Access
Abstract
Slides
Like
Thumbnail

Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.

Speaker: Doctor Z. Cheng (Chengdu, CN)

Access
Abstract
Slides
Like
Thumbnail

Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience

Speaker: Doctor S. Mahmood (Detroit, US)

Access
Abstract
Slides
Like
Thumbnail

Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis

Speaker: Doctor T. Sugimoto (Nagoya, JP)

Access
Abstract
Slides
Like
Thumbnail

Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI

Speaker: Doctor V. Jimenez Franco (San Pedro Garza Garcia, MX)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Valvular heart disease and infective endocarditis e-posters

Speakers: Ms R. Dirsiene, Doctor N. Ngiam, Doctor Z. Cheng, Doctor S. Mahmood, Doctor T. Sugimoto...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources